(Q45183631)

10 December 2017

A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders (English)

1 reference

stem cell transplantation

10 December 2017

1 reference

5

1 reference

10 December 2017

Shenoy S

1

1 reference

10 December 2017

Grossman WJ

2

1 reference

10 December 2017

DiPersio J

3

1 reference

10 December 2017

Yu LC

4

1 reference

10 December 2017

Barnes YJ

6

1 reference

10 December 2017

Mohanakumar T

7

1 reference

10 December 2017

Rao A

8

1 reference

10 December 2017

Hayashi RJ

9

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Bone Marrow Transplantation

10 December 2017

1 reference

10 December 2017

35

1 reference

10 December 2017

4

1 reference

10 December 2017

345-352

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704795

10 December 2017

0 references

cites work

Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Bone marrow transplantation in sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Bone marrow transplantation for beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Bone marrow transplantation for beta-thalassemia: the University of California San Francisco experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Outcome of single fraction total body irradiation-conditioned stem cell transplantation in younger children with malignant disease--comparison with a busulphan-cyclophosphamide regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Endocrine complications of bone marrow transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Infectious complications following T-cell depleted hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

7 January 2021

T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated don

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

7 January 2021

Severe neurologic complications after hematopoietic stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

7 January 2021

Surface of human sperm bears three differently charged CD52 forms, two of which remain stably bound to sperm after capacitation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

7 January 2021

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

7 January 2021

Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

7 January 2021

IMMUNE RECONSTITUTION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION DEPLETED OF T CELLS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

7 January 2021

The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

7 January 2021

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

7 January 2021

Enterovirus infections following T-cell depleted allogeneic transplants in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

7 January 2021

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704795

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704795

1 reference

Dimensions Publication ID

10 December 2017

0 references

1 reference